BIOMOLECULAR CONTRAST AGENTS FOR THERAPY OPTIMIZATION IN RADIATION THERAPY WITH PROTON OR ION BEAMS

摘要

Bio-molecular contrast agents (BMCA) can be used for optimizing radiation dosage, energy and/ or duration in order to achieve on-line, real-time therapy optimization. The BMCA signals during treatment are compared with expected values to determine what, if any, therapy optimization is needed.